ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions.

October 7, 2005

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002